SEC Form 4 · accession 0001493152-18-002842
PetLife Pharmaceuticals, Inc. · PTLF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ramana Vivek
Officer — Chief Medical Officer
Period of report
Oct 27, 2016
Accepted (ET)
Mar 2, 2018 · 3:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001354591
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 27, 2016 | A | 1,000,000 | $0.67 | A | 2,000,000 | D | |
| Common StockF2 | Aug 17, 2017 | J | 1,000,000 | — | D | 1,000,000 | D | |
| Series A Preferred StockF2 | Aug 17, 2017 | J | 1,000,000 | — | A | 1,000,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Issued shares as compensation pursuant to employment contract.
- F2Conversion of common stock into Series A Preferred Stock on a 1:1 basis.